NC
QNTM

NewSquare Capital’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

NewSquare Capital’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1
Closed – – 417
2020
Q2 		$0 Buy
+1
New +$234 ﹤0.01% 455

Other funds holding QNTM

WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

NewSquare Capital's QNTM Position: Q3 2020 in Review

NewSquare Capital sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q3 2020, closing a stake of 1 share.

NewSquare Capital first reported a position in QNTM in Q2 2020 and held it in 1 quarter. The position peaked at $0 in Q2 2020. 14 funds tracked by Wall St. Rank hold QNTM as of Q3 2020.

  • NewSquare Capital reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q3 2020 after selling out during the quarter.
  • NewSquare Capital sold 1 Quantum Biopharma Class B Subordinate Voting Shares share in Q3 2020.
  • NewSquare Capital first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q2 2020 and held it in 1 quarter.
  • NewSquare Capital's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $0 in Q2 2020.
  • 14 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q3 2020.

Based on NewSquare Capital's 13F filing for Q3 2020, filed 4 Nov 2020.